A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Clinical trial NCT06805825 · RECRUITING

Trial details

NCT number: NCT06805825
Sponsor: Novelty Nobility, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumors Small-cell Lung Cancer Adenoid Cystic Carcinoma Uveal Melanoma Neuroendocrine Tumors Chromophobe Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma

Start date: 2025-02-03
Primary completion: 2027-08-30
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.